New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Patient-Derived Cancer Stem Cells Offer Diagnostic and Therapeutic Potential in Brain Cancer

Patient-Derived Cancer Stem Cells Offer Diagnostic and Therapeutic Potential in Brain Cancer

March 1, 2017John S. Kuo, MD, PhD, FAANS, FACSA brain tumor research group at the UW Carbone Cancer Center focuses on biological studies of patient-derived glioblastoma multiforme (GBM) cancer stem ce
World medicine November 21,2023
Patient-Derived Cancer Stem Cells Offer Diagnostic and Therapeutic Potential in Brain Cancer

Patient-Derived Cancer Stem Cells Offer Diagnostic and Therapeutic Potential in Brain Cancer

March 1, 2017John S. Kuo, MD, PhD, FAANS, FACSA brain tumor research group at the UW Carbone Cancer Center focuses on biological studies of patient-derived glioblastoma multiforme (GBM) cancer stem ce
World medicine November 21,2023
No Age Limit for Bone Marrow Transplantation

No Age Limit for Bone Marrow Transplantation

October 10, 2013Rainer Storb, MDAge is no longer a consideration when determining whether an older patient with blood cancer is a candidate for stem cell transplantation.Rainer Storb, MDMember, Clinic
World medicine November 21,2023
No Age Limit for Bone Marrow Transplantation

No Age Limit for Bone Marrow Transplantation

October 10, 2013Rainer Storb, MDAge is no longer a consideration when determining whether an older patient with blood cancer is a candidate for stem cell transplantation.Rainer Storb, MDMember, Clinic
World medicine November 21,2023
Grant Aims to Deliver First Stem-Cell Immunotherapy in Ovarian Cancer

Grant Aims to Deliver First Stem-Cell Immunotherapy in Ovarian Cancer

January 19, 2015Christin MeltonThe New York State Stem Cell Science Program recently awarded a 4-year $11.9 million grant to Roswell Park Cancer Institute to fund research and development of a stem-ce
World medicine November 21,2023
Grant Aims to Deliver First Stem-Cell Immunotherapy in Ovarian Cancer

Grant Aims to Deliver First Stem-Cell Immunotherapy in Ovarian Cancer

January 19, 2015Christin MeltonThe New York State Stem Cell Science Program recently awarded a 4-year $11.9 million grant to Roswell Park Cancer Institute to fund research and development of a stem-ce
World medicine November 21,2023
Stem Cell Transplantation Feasible in Elderly Patients With Myeloma

Stem Cell Transplantation Feasible in Elderly Patients With Myeloma

September 6, 2018Jason HarrisAndrew L. Pecora, MD, discusses the use of autologous stem cell transplantation in patients aged ≥75 years and the future of care in multiple myeloma.Andrew L. Pecora, MD,
World medicine November 21,2023
Stem Cell Transplantation Feasible in Elderly Patients With Myeloma

Stem Cell Transplantation Feasible in Elderly Patients With Myeloma

September 6, 2018Jason HarrisAndrew L. Pecora, MD, discusses the use of autologous stem cell transplantation in patients aged ≥75 years and the future of care in multiple myeloma.Andrew L. Pecora, MD,
World medicine November 21,2023
Role of Stem Cell Transplantation Evolving in Multiple Myeloma

Role of Stem Cell Transplantation Evolving in Multiple Myeloma

March 11, 2015Laura PanjwaniOncLive interviewed Ravi Vij, MD, associate professor, Division of Oncology, Section of Bone Marrow Transplantation, Washington University School of Medicine and the Sitema
World medicine November 21,2023
Role of Stem Cell Transplantation Evolving in Multiple Myeloma

Role of Stem Cell Transplantation Evolving in Multiple Myeloma

March 11, 2015Laura PanjwaniOncLive interviewed Ravi Vij, MD, associate professor, Division of Oncology, Section of Bone Marrow Transplantation, Washington University School of Medicine and the Sitema
World medicine November 21,2023
Stem Cell Transplant Continues to Show Benefit in 'Novel-Agent Era' of Multiple Myeloma

Stem Cell Transplant Continues to Show Benefit in 'Novel-Agent Era' of Multiple Myeloma

May 18, 2016Laura PanjwaniEarly findings from a phase III clinical trial suggest that patients with multiple myeloma who receive upfront autologous stem cell transplant survive longer without disease
World medicine November 21,2023
Stem Cell Transplant Continues to Show Benefit in 'Novel-Agent Era' of Multiple Myeloma

Stem Cell Transplant Continues to Show Benefit in 'Novel-Agent Era' of Multiple Myeloma

May 18, 2016Laura PanjwaniEarly findings from a phase III clinical trial suggest that patients with multiple myeloma who receive upfront autologous stem cell transplant survive longer without disease
World medicine November 21,2023
Stem Cell Transplant Feasible, Highly Effective for HIV-Associated Lymphoma

Stem Cell Transplant Feasible, Highly Effective for HIV-Associated Lymphoma

December 8, 2014Silas InmanPatients with HIV-associated lymphoma can effectively be treated with autologous hematopoietic stem cell transplantation, with outcomes that are similar to patients without
World medicine November 21,2023
Stem Cell Transplant Feasible, Highly Effective for HIV-Associated Lymphoma

Stem Cell Transplant Feasible, Highly Effective for HIV-Associated Lymphoma

December 8, 2014Silas InmanPatients with HIV-associated lymphoma can effectively be treated with autologous hematopoietic stem cell transplantation, with outcomes that are similar to patients without
World medicine November 21,2023
Stem Cell Transplantation May Impair Sexual Health

Stem Cell Transplantation May Impair Sexual Health

December 3, 2013Jill SteinBoth men and women report a significant decline in sexual satisfaction after hematopoietic cell transplantation that is sustained at 3-year follow-up.F. Lennie Wong, PhDBoth
World medicine November 21,2023
Stem Cell Transplantation May Impair Sexual Health

Stem Cell Transplantation May Impair Sexual Health

December 3, 2013Jill SteinBoth men and women report a significant decline in sexual satisfaction after hematopoietic cell transplantation that is sustained at 3-year follow-up.F. Lennie Wong, PhDBoth
World medicine November 21,2023
Stem Cell Transplant Techniques Evolving to Include More Patient Populations

Stem Cell Transplant Techniques Evolving to Include More Patient Populations

June 20, 2017Gina ColumbusTsiporah B. Shore, MD, discusses some of these newer advancements related to stem cell transplantation and the challenges with including patients in ethnic populations.Tsipor
World medicine November 21,2023
Stem Cell Transplant Techniques Evolving to Include More Patient Populations

Stem Cell Transplant Techniques Evolving to Include More Patient Populations

June 20, 2017Gina ColumbusTsiporah B. Shore, MD, discusses some of these newer advancements related to stem cell transplantation and the challenges with including patients in ethnic populations.Tsipor
World medicine November 21,2023
Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma

Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma

August 8, 2018Caroline SeymourNoa Biran, MD, discusses patient-reported outcomes following autologous stem cell transplant in patients with myeloma.Noa Biran, MDPreliminary pilot data presented at the
World medicine November 21,2023
Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma

Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma

August 8, 2018Caroline SeymourNoa Biran, MD, discusses patient-reported outcomes following autologous stem cell transplant in patients with myeloma.Noa Biran, MDPreliminary pilot data presented at the
World medicine November 21,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com